Form 8.5 (EPT/RI)-Amend-ADVANCED MEDICAL SOLUTIONS
Summary by AI BETAClose X
Amendment – due to the amendment of Equity and Derivative transactions, the disclosure made on 07 October for dealings on 06 October has been updated. Section 2(a) and 2(b) has been updated.
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
|
(a) Name of exempt principal trader: |
(GS) GOLDMAN SACHS INTERNATIONAL |
|
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree |
ADVANCED MEDICAL SOLUTIONS GROUP PLC |
|
(c) Name of the party to the offer with which exempt principal trader is connected: |
H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES INC (A WHOLLY-OWNED SUBSIDIARY OF H.B. FULLER COMPANY) |
|
(d) Date dealing undertaken: |
06 October 2026 |
|
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" |
N/A |
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
|
Class of relevant security |
Purchases/ sales
|
Total number of securities |
Highest price per unit paid/received |
Lowest price per unit paid/received |
|
5p ordinary |
Purchases |
32,041 |
2.8250 GBP |
2.8150 GBP |
|
5p ordinary |
Sales |
615,604 |
2.8225 GBP |
2.8200 GBP |
(b) Cash-settled derivative transactions
|
Class of relevant security |
Product description e.g. CFD |
Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position |
Number of reference securities |
Price per unit |
|
5p ordinary |
CFD |
Opening a short position |
1,268 |
2.8152 GBP |
|
5p ordinary |
CFD |
Reducing a long position |
5,128 |
2.8173 GBP |
|
5p ordinary |
CFD |
Reducing a short position |
51,049 |
2.8200 GBP |
|
5p ordinary |
CFD |
Increasing a long position |
234 |
2.8218 GBP |
|
5p ordinary |
CFD |
Increasing a short position |
11,700 |
2.8244 GBP |
|
5p ordinary |
CFD |
Reducing a short position |
505 |
2.8247 GBP |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
|
Class of relevant security |
Product description e.g. call option |
Writing, purchasing, selling, varying etc. |
Number of securities to which option relates |
Exercise price per unit |
Type e.g. American, European etc. |
Expiry date |
Option money paid/ received per unit |
|
|
|
|
|
|
|
|
|
(ii) Exercise
|
Class of relevant security |
Product description e.g. call option |
Exercising / exercised against |
Number of securities |
Exercise price per unit |
|
|
|
|
|
|
(d) Other dealings (including subscribing for new securities)
|
Class of relevant security |
Nature of dealing e.g. subscription, conversion |
Details |
Price per unit (if applicable) |
|
|
|
|
|
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
|
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” |
|
NONE
|
(b) Agreements, arrangements or understandings relating to options or derivatives
|
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” |
|
NONE
|
Date of disclosure: |
04 November 2026 |
Contact name: |
Papa Lette and Andrzej Szyszka |
Telephone number: |
+33(1) 4212 1459 / +48(22) 317 4817 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 5 hours ago Luceco
- 5 hours ago Helios Towers
- 5 hours ago Wise Class A
- 6 hours ago EDX Medical Group Plc
- 6 hours ago Naked Wines